Skip to main content
Premium Trial:

Request an Annual Quote

Thomas Jefferson U, Pyrosequencing in IBD Research Collaboration

NEW YORK, March 31 - Thomas Jefferson University has purchased a PSQ HS 96A genotyping system from Pyrosequencing as part of a collaborative agreement to analyze genes and develop applications for inflammatory bowel disease (IBD), the company said today.


The university will use the genotyping system to study genetic variations in genes related to IBD. Ultimately, it plans to develop a gene-based diagnostic tool "that we expect to be much simpler and faster, while as effective as current methods," said Paolo Fortina, professor of Medicine at Jefferson Medical College of Thomas Jefferson University.


Pyrosequencing will commercialize any molecular diagnostic products relating to the IBD research in collaboration with a third party, said Jerry Williamson, president of Pyrosequencing.


The agreement builds on an existing collaboration between Pyrosequencing and Fortina on gene-based diagnostic tests for hearing loss. Fortina used Pyrosequencing's technology to study variations in the connexin 26 gene implicated in a common type of inherited hearing loss.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.